Literature DB >> 9414190

Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland.

S Pilotti1, P Collini, L Mariani, M Placucci, I Bongarzone, P Vigneri, S Cipriani, F Falcetta, R Miceli, M A Pierotti, F Rilke.   

Abstract

We reclassified 720 nonmedullary invasive thyroid carcinomas diagnosed and treated between 1975 and 1993. Twenty-seven cases met the criteria of insular carcinoma and 29 cases those of widely invasive follicular carcinoma. Comparison of these histotypes with respect to pathologic stage and overall, relative, and visceral metastasis-free survival showed a significant association between histotype and pT and pN categories. In particular, pT4 (p < 0.001) and pN1 (p < 0.001) categories were more frequent in the insular carcinoma histotype. By contrast, no significant differences in overall, relative, or visceral metastasis-free survival were observed between insular carcinoma and widely invasive follicular carcinoma. Molecular analysis by polymerase chain reaction-single-strand conformation polymorphism demonstrated RAS gene family point mutations in five of eight cases analyzed in each of the two histotypes, with a high proportion of CAA-->AAA transversion at codon 61 of the N-RAS gene in insular carcinoma. These findings suggest that insular carcinoma represents a de novo entity distinct from widely invasive follicular carcinoma, that widely invasive follicular carcinoma has biologic characteristics more consistent with poorly differentiated than well-differentiated carcinomas, and that both insular carcinoma and widely invasive follicular carcinoma share similar molecular alterations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9414190     DOI: 10.1097/00000478-199712000-00009

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  26 in total

Review 1.  Poorly differentiated thyroid carcinoma: introduction to the issue, its landmarks, and clinical impact.

Authors:  Juan Rosai
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

Review 2.  How to define follicular thyroid carcinoma?

Authors:  Kurt Werner Schmid; Nadir Rashad Farid
Journal:  Virchows Arch       Date:  2006-02-28       Impact factor: 4.064

Review 3.  An evidence-based review of poorly differentiated thyroid cancer.

Authors:  Enoch M Sanders; Virginia A LiVolsi; James Brierley; Jennifer Shin; Gregory W Randolph
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

Review 4.  Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.

Authors:  Eleonora Molinaro; Cristina Romei; Agnese Biagini; Elena Sabini; Laura Agate; Salvatore Mazzeo; Gabriele Materazzi; Stefano Sellari-Franceschini; Alessandro Ribechini; Liborio Torregrossa; Fulvio Basolo; Paolo Vitti; Rossella Elisei
Journal:  Nat Rev Endocrinol       Date:  2017-07-14       Impact factor: 43.330

5.  Nodal metastasis in well-differentiated follicular carcinoma of the thyroid: Its incidence and clinical significance.

Authors:  Mitsuyoshi Hirokawa; Yasuhiro Ito; Seiji Kuma; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Akira Miyauchi
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

6.  Insular carcinomas of the thyroid exhibit poor prognosis and long-term survival in comparison to follicular and papillary T4 carcinomas.

Authors:  Ayman Agha; Gabriel Glockzin; Matthias Woenckhaus; Wolfgang Dietmaier; Igors Iesalnieks; Hans J Schlitt
Journal:  Langenbecks Arch Surg       Date:  2007-01-10       Impact factor: 3.445

7.  Identification of a novel HRAS variant and its association with papillary thyroid carcinoma.

Authors:  Rui Dou; Lili Zhang; Tingxia Lu; Dong Liu; Fang Mei; Jian Huang; Linxue Qian
Journal:  Oncol Lett       Date:  2018-01-17       Impact factor: 2.967

8.  Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours.

Authors:  Marco Volante; Mauro Papotti
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

9.  Multifocality predicts poor outcome of patients with insular thyroid cancer: a clinicopathological study.

Authors:  Lei Liu; Dapeng Li; Hailing Wang; Xiaoyong Yang; Yang Yu; Ming Gao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Lack of mutational events of RAS genes in sporadic thyroid cancer but high risk associated with HRAS T81C single nucleotide polymorphism (case-control study).

Authors:  Mosin S Khan; Arshad A Pandith; Mahboob Ul Hussain; Mohammad Iqbal; Nighat P Khan; Khurshid A Wani; Shariq R Masoodi; Syed Mudassar
Journal:  Tumour Biol       Date:  2012-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.